×
About 49,020 results

ALLMedicine™ Addiction Center

Research & Reviews  14,258 results

Just-In-Time Adaptive Interventions for Addictive Behaviors
https://clinicaltrials.gov/ct2/show/NCT03538652

Jul 1st, 2022 - BACKGROUND: Our research group has made extensive use of ecological momentary assessment (EMA) to understand people s daily experiences with opioid craving, use, and lapse. We have also administered clinic-based psychotherapies such as cognitive-b...

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity
https://clinicaltrials.gov/ct2/show/NCT01867411

Jul 1st, 2022 - Objective: To develop a neuroimaging/genetic/epigenetic biomarker of nicotine dependence severity that may be useful in predicting success in smoking cessation and in development of new smoking cessation treatment targets. Further, by evaluating t...

Imaging Biomarker for Addiction Treatment Outcome
https://clinicaltrials.gov/ct2/show/NCT03427424

Jul 1st, 2022 - Objective: Despite recent advances in addiction neuroscience, achieving a breakthrough in predicting addiction treatment outcome has been difficult and long-term abstinence success unacceptably low. The aim of this study is to create a biomarker u...

Characterization of Phenotypic and Genotypic Regressors for Imaging
https://clinicaltrials.gov/ct2/show/NCT01148381

Jul 1st, 2022 - Objective: To determine genetic variants as well as behavioral measures across different study group populations. Results of these will be used as regressors to help explain inter-individual differences in data collected across IRP protocols. Stud...

Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
https://clinicaltrials.gov/ct2/show/NCT02911077

Jul 1st, 2022 - The microbiome exists in a complex symbiotic relationship with its human host, the characterization of which is imperative for understanding a myriad of diseases. Until recently, much of gut microbiome research has focused on gastrointestinal diso...

see more →

Guidelines  16 results

Clinical guideline highlights for the hospitalist: 2020 American Society of Addiction M...
https://doi.org/10.12788/jhm.3729
Journal of Hospital Medicine; Ganatra RB, Breu AC et. al.

Dec 16th, 2021 - The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management RELEASE DATE: May 2020 PRIOR VERSION: 2004 American Society of Addiction Medicine guideline on management of alcohol withdrawal delirium DEVELOPER: American Society of Addiction...

Medication for Adolescents and Young Adults With Opioid Use Disorder.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902443
The Journal of Adolescent Health : Official Publication O...

Jan 25th, 2021 - Opioid-related morbidity and mortality have risen in many settings globally. It is critical that practitioners who work with adolescents and young adults (AYAs) provide timely, evidence-based treatment for opioid use disorder (OUD). Such treatment...

Executive Summary of the American Society of Addiction Medicine (ASAM) Clinical Practic...
https://doi.org/10.1097/ADM.0000000000000732
Journal of Addiction Medicine; Lindsay DL, Freedman K et. al.

Sep 11th, 2020 - : The American Society of Addiction Medicine (ASAM) Clinical Practice Guideline on Alcohol Withdrawal Management provides guidance on the identification and management of alcohol withdrawal in adults with varying degrees of syndrome severity. The ...

Executive Summary of the Focused Update of the ASAM National Practice Guideline for the...
https://doi.org/10.1097/ADM.0000000000000635
Journal of Addiction Medicine; Crotty K, Freedman KI et. al.

Mar 27th, 2020 - : A Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder is published in the current issue of the Journal of Addiction Medicine. The focused update included a search of Medline's PubMed database from Janu...

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of th...
https://doi.org/10.1016/j.ajog.2019.03.022
American Journal of Obstetrics and Gynecology; Ecker J, Abuhamad A et. al.

Apr 1st, 2019 - Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American So...

see more →

Drugs  1,074 results see all →

Clinicaltrials.gov  1,492 results

Just-In-Time Adaptive Interventions for Addictive Behaviors
https://clinicaltrials.gov/ct2/show/NCT03538652

Jul 1st, 2022 - BACKGROUND: Our research group has made extensive use of ecological momentary assessment (EMA) to understand people s daily experiences with opioid craving, use, and lapse. We have also administered clinic-based psychotherapies such as cognitive-b...

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity
https://clinicaltrials.gov/ct2/show/NCT01867411

Jul 1st, 2022 - Objective: To develop a neuroimaging/genetic/epigenetic biomarker of nicotine dependence severity that may be useful in predicting success in smoking cessation and in development of new smoking cessation treatment targets. Further, by evaluating t...

Imaging Biomarker for Addiction Treatment Outcome
https://clinicaltrials.gov/ct2/show/NCT03427424

Jul 1st, 2022 - Objective: Despite recent advances in addiction neuroscience, achieving a breakthrough in predicting addiction treatment outcome has been difficult and long-term abstinence success unacceptably low. The aim of this study is to create a biomarker u...

Characterization of Phenotypic and Genotypic Regressors for Imaging
https://clinicaltrials.gov/ct2/show/NCT01148381

Jul 1st, 2022 - Objective: To determine genetic variants as well as behavioral measures across different study group populations. Results of these will be used as regressors to help explain inter-individual differences in data collected across IRP protocols. Stud...

Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
https://clinicaltrials.gov/ct2/show/NCT02911077

Jul 1st, 2022 - The microbiome exists in a complex symbiotic relationship with its human host, the characterization of which is imperative for understanding a myriad of diseases. Until recently, much of gut microbiome research has focused on gastrointestinal diso...

see more →

News  2,733 results

Why do we treat menopause as a disease?
https://www.mdedge.com/obgyn/article/255511/menopause/why-do-we-treat-menopause-disease
Marcia Frellick

Jun 17th, 2022 - Menopause gets a bad rap in medical literature and throughout society, say authors of a new analysis. And they argue that the negativity undermines women’s health outlook in the years that should be a natural life transition.

Meme Stocks and Meme Coin: A Cautionary Tale of Addiction
https://www.medscape.com/viewarticle/974736

Jun 10th, 2022 - I bet you or someone you know bought a meme stock or meme coin in the past year. It was all the rage and probably induced some feelings of FOMO (fear of missing out). Even if you weren't involved, you probably saw a headline on the news or even br...

Managing Mental Health and Substance Abuse In HIV Patients
https://www.medscape.com/viewarticle/963241

Jun 7th, 2022 - This transcript has been edited for clarity. Michael Saag, MD: Hello. I'm Dr Michael Saag, and welcome to Medscape InDiscussion: HIV. Today we're talking about managing mental health and substance abuse in patients with HIV. I picked this topic be...

Cannabis on Par With Opioids for Pain Relief, Study Suggests
https://www.medscape.com/viewarticle/975155

Jun 7th, 2022 - Cannabis-based products may control chronic pain as effectively as opioids, but adverse effects are common, and long-term safety remains unknown, according to a new study. Several other systematic reviews have recently evaluated cannabinoids for t...

Cannabis may relieve pain as effectively as opioids, but more research is needed
https://www.mdedge.com/familymedicine/article/255235/pain/cannabis-may-relieve-pain-effectively-opioids-more-research
MDedge Family Medicine; Will Pass

Jun 6th, 2022 - Cannabis-based products may control chronic pain as effectively as opioids, but adverse effects are common, and long-term safety remains unknown, according to a new study. Several other systematic reviews have recently evaluated cannabinoids for t.

see more →

Patient Education  35 results see all →